Rolvedon 13.2 mg/.6mL
eflapegrastim-xnst · INJECTION, SOLUTION · Spectrum Pharmaceuticals, Inc.
Rolvedon is a injection, solution containing eflapegrastim-xnst at 13.2 mg/.6mL, taken subcutaneous. Manufactured by Spectrum Pharmaceuticals, Inc..
Key Facts
- Brand Name
- Rolvedon
- Generic Name
- eflapegrastim-xnst
- NDC Code (Product)
76961-101- Manufacturer
- Spectrum Pharmaceuticals, Inc.
- Strength
- 13.2 mg/.6mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- BLA761148
- Drug Class
- Leukocyte Growth Factor [EPC]
- Marketing Start
- 10/18/2022
Recall History
No Recall HistoryFrequently Asked Questions
What is Rolvedon used for?
Rolvedon contains eflapegrastim-xnst. It is a injection, solution taken subcutaneous. Consult your doctor for specific uses.
Is Rolvedon a controlled substance?
Rolvedon is not classified as a controlled substance by the DEA.
What is the generic name for Rolvedon?
The generic name for Rolvedon is eflapegrastim-xnst. There are no other listed brand versions of eflapegrastim-xnst.
What is the NDC code for Rolvedon 13.2 mg/.6mL?
The NDC (National Drug Code) for Rolvedon 13.2 mg/.6mL is 76961-101, listed by Spectrum Pharmaceuticals, Inc..
Other Rolvedon Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)